| Ref ID | 1046 |
| First Author | O. Montero Perez |
| Journal | PHARMACOLOGY RESEARCH & PERSPECTIVES |
| Year Of Publishing | 2024 |
| URL | https://bpspubs.onlinelibrary.wiley.com/doi/10.1002/prp2.1195 |
| Keywords |
• Low methodological quality • General medical • Pharmacological • Protocols |
| Problem(s) |
• Reasons for excluding potentially eligible studies not provided • Conflicts of interest or funding of included studies not assessed • Low methodological (AMSTAR) quality • No registered or published protocol |
| Article Type | Empirical |
| Article Subtype | Cross-sectional survey/Methodological systematic review |
| First Author Country | Spain |
| Checklists |
• AMSTAR 2 |
| Aim | To assess the methodological quality (AMSTAR2) of published systematic reviews of the impact of pharmacists' interventions on health-related outcomes measured in asthma patients indexed across PubMed, Embase, Scopus, and Cochrane Library from inception to December 2022. |
| Level of Investigation | Descriptive |
| Summary of Findings | From 9 systematic reviews indexed across PubMed, Embase, Scopus, and Cochrane Library from inception to December 2022. Of the nine systematic reviews included, six were judged critically low quality using AMSTAR 2. Only 2 of the reviews (22.2%) provided a list of excluded studies or reported on the sources of funding for the studies included in the review. Three reviews (33.3%) did not report a protocol or performed study selection in duplicate. |
| Number of systematic reviews included | 9 |
| Number of eligible systematic reviews assessed | 217 |
| Treatment impacted | Not Applicable |
| Treatment impacted description | |
| Interpretation impacted | Not Applicable |
| Interpretation impacted description |